MDS-157 Luspatercept Versus Epoetin Alfa (EA) for Treatment of Anemia in Patients With Erythropoiesis-Stimulating Agent (ESA)-Naive Lower-Risk Myelodysplastic Syndromes (LR-MDS) Requiring Red Blood Cell (RBC) Transfusions: Data from the Phase III COMMANDS Study
G. Garcia-Manero, U. Platzbecker, V. Santini, A. Zeidan, P. Fenaux, R. Komrokji, J. Shortt, D. Valcárcel, A. Jonášová, S. Dimicoli-Salazar, I. Tiong, Chien-Chin Lin, Jiahui Li, Jennie Zhang, A. C. Giuseppi, S. Kreitz, Veronika P. Pozharskaya, K. Keeperman, S. Rose, J. Shetty, Sheida Hayati, S. Vodala, Andrius Degulys, S. Paolini, T. Cluzeau, M. D. Porta
{"title":"MDS-157 Luspatercept Versus Epoetin Alfa (EA) for Treatment of Anemia in Patients With Erythropoiesis-Stimulating Agent (ESA)-Naive Lower-Risk Myelodysplastic Syndromes (LR-MDS) Requiring Red Blood Cell (RBC) Transfusions: Data from the Phase III COMMANDS Study","authors":"G. Garcia-Manero, U. Platzbecker, V. Santini, A. Zeidan, P. Fenaux, R. Komrokji, J. Shortt, D. Valcárcel, A. Jonášová, S. Dimicoli-Salazar, I. Tiong, Chien-Chin Lin, Jiahui Li, Jennie Zhang, A. C. Giuseppi, S. Kreitz, Veronika P. Pozharskaya, K. Keeperman, S. Rose, J. Shetty, Sheida Hayati, S. Vodala, Andrius Degulys, S. Paolini, T. Cluzeau, M. D. Porta","doi":"10.1016/s2152-2650(23)01169-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"69 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)01169-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}